Heartflow (NASDAQ:HTFL) Trading Down 10.6% – What’s Next?

Heartflow, Inc. (NASDAQ:HTFL)’s stock price was down 10.6% on Thursday . The stock traded as low as $31.94 and last traded at $31.94. Approximately 74,635 shares traded hands during trading, a decline of 82% from the average daily volume of 404,881 shares. The stock had previously closed at $35.74.

Wall Street Analyst Weigh In

HTFL has been the topic of several research reports. Zacks Research raised Heartflow to a “hold” rating in a research report on Wednesday, September 3rd. Weiss Ratings started coverage on shares of Heartflow in a research report on Saturday, November 1st. They issued a “sell (d+)” rating for the company. Stifel Nicolaus started coverage on shares of Heartflow in a research note on Tuesday, September 2nd. They issued a “buy” rating and a $35.00 target price for the company. Piper Sandler initiated coverage on shares of Heartflow in a report on Tuesday, September 2nd. They issued an “overweight” rating and a $38.00 price objective on the stock. Finally, Canaccord Genuity Group increased their price target on Heartflow from $35.00 to $39.00 and gave the company a “buy” rating in a report on Monday, September 22nd. Four investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $36.60.

Heartflow Stock Down 13.8%

The company’s 50-day moving average is $34.73.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Friday, September 19th. The company reported ($1.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.26). The company had revenue of $43.42 million for the quarter, compared to analyst estimates of $43.20 million.

Institutional Trading of Heartflow

Several large investors have recently added to or reduced their stakes in the business. Capital International Investors acquired a new position in Heartflow during the 3rd quarter worth $43,671,000. JPMorgan Chase & Co. bought a new stake in shares of Heartflow during the third quarter valued at about $13,887,000. TD Asset Management Inc bought a new position in Heartflow in the 3rd quarter valued at about $2,692,000. Legato Capital Management LLC acquired a new position in Heartflow during the 3rd quarter valued at about $243,000. Finally, Artisan Partners Limited Partnership bought a new stake in shares of Heartflow during the 3rd quarter worth about $16,817,000.

Heartflow Company Profile

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.